(1 - 2 von 2
)
Efficacy Data Presented for iVascular's Luminor DCB - Endovascular...
evtoday.com
Professor Ulf Teichgräber, MD, presented the results on the primary endpoint of late lumen loss (LLL) and the clinical 6-month results from the full cohort of the EffPAC randomized controlled trial. The data demonstrated the effectiveness of Luminor DCB versus plain old balloon angioplasty (POBA) in the ...
Luminor drug-coated balloon EffPAC study shows efficacy at six months
vascularnews.com
Ulf Teichgräber, director of the Departement of Radiology of the University Hospital Jena, Germany, presented the new, primary endpoint late lumen loss and the clinical six-months results from the full cohort of the EFFPAC Randomized Control Study, demonstrating the effectiveness of Luminor DCB versus ...
sortiert nach Relevanz / Datum